CAMK2A and glioblastoma: TCGA data in different types of GBMs showed CaMK2A expression, albeit lower than the normal tissues (Figure 1) and other studies also supports this finding in GBM (Jayaram et al., 2016) suggesting that tumor cells “need” but “keeps low levels” of this kinase in comparison to “normal controls”.